Your Biopsy Was Non-Diagnostic (Bethesda I): What Happens Now
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
A Bethesda I result is the most frustrating kind of biopsy outcome. The needle was used, the doctor performed a good technical biopsy, the days of waiting passed, and the result was essentially that the biopsy did not produce enough information to answer the question. This is not a cancer finding. It is a procedural outcome. Understanding why it happens, how often a second biopsy succeeds, and what the rare exceptions look like is what turns this from an confusing situation into a manageable one.
The Bethesda system requires a minimum number of well-preserved thyroid cells (typically six clusters of at least ten cells each) to make a reliable assessment. When the sample does not meet this threshold, the pathologist categorizes the result as Bethesda I, non-diagnostic, or unsatisfactory. This happens in approximately 5 to 15% of thyroid biopsies in published series, with the rate depending heavily on the experience of the person performing the biopsy and the characteristics of the nodule.
The malignancy risk associated with a Bethesda I result is approximately 1 to 4%, similar to the malignancy risk for nodules that have never been biopsied. A non-diagnostic biopsy does not raise concern beyond what already existed.
Why Bethesda I Results Happen
-
Cystic component: Nodules with significant fluid components often yield mostly fluid rather than diagnostic cells. This is the most common reason for a non-diagnostic biopsy.
-
Sampling technique: The biopsy needle may have missed the solid portion of the nodule. Operator experience makes a significant difference.
-
Bloody specimen: Blood obscures the cells and reduces the number of evaluable cells.
-
Calcifications: A heavily calcified nodule can be difficult to sample.
-
Deep or small nodules: Nodules in difficult locations or under 1 cm can be technically harder to biopsy completely.
⚕ Clinical note A non-diagnostic biopsy says more about the procedure than about the nodule. It is not a sign that the nodule is unusual or concerning. A repeat biopsy under experienced hands produces a diagnostic result in approximately 60 to 80% of cases.
What Comes Next
The standard recommendation after a Bethesda I result is repeat biopsy, with technical adjustments to improve the yield. The repeat is usually performed at least 6 to 8 weeks after the first biopsy to allow any inflammation to settle. Several adjustments improve the success of the repeat.
-
Performed by a more experienced operator: If the first biopsy was performed by a general radiologist, a referral to a thyroid-focused radiologist or a doctor who performs ultrasound-guided biopsies regularly is reasonable.
-
Targeted sampling of the solid portion: For cystic nodules, the solid mural component is specifically targeted rather than the fluid.
-
Increased number of passes: Most experienced operators do 3 to 5 needle passes to ensure an adequate specimen.
-
On-site cytology assessment: At some centers, a pathologist is in the room during the biopsy to confirm adequacy before the patient leaves.
| Second Biopsy Outcome | Approximate Frequency |
|---|---|
| Diagnostic result (Bethesda II through VI) | Approximately 60 to 80%. |
| Second non-diagnostic result | Approximately 20 to 40%. |
If a Second Bethesda I Result Happens
A persistently non-diagnostic biopsy after two attempts changes the calculation slightly. For low-suspicion nodules that remain non-diagnostic, ongoing ultrasound surveillance is reasonable. For higher-suspicion nodules that remain non-diagnostic, the options include core-needle biopsy (a slightly larger needle that yields more tissue), molecular testing on the existing specimen, or diagnostic thyroid lobectomy. The choice depends on the ultrasound features and the patient’s overall situation.
⚕ Clinical note: For a highly suspicious nodule that has produced two non-diagnostic biopsies, diagnostic thyroid lobectomy becomes a reasonable consideration. The ultrasound features carry enough independent risk that waiting indefinitely is not a good option. This is uncommon but worth knowing about for patients in this specific situation.
What to Ask Before the Repeat Biopsy
-
Who will perform the repeat biopsy: A thyroid-experienced operator is preferred. If your first biopsy was at a general radiology practice and the result was non-diagnostic, asking for a thyroid-focused practitioner for the repeat is reasonable.
-
What is the cystic component of the nodule: If the nodule is mostly cystic, the strategy needs to specifically target the solid component.
-
Will on-site cytology be available: Not available everywhere, but it improves first-pass success when offered.
-
What is the plan if the repeat is also non-diagnostic: Settling this in advance prevents an extended period of uncertainty if a third sample is needed.
The Bottom Line
A Bethesda I result is a procedural outcome, not a cancer finding. It happens in approximately 5 to 15% of thyroid biopsies. The standard recommendation is a repeat biopsy after 6 to 8 weeks, ideally with technical adjustments and an experienced operator. Most repeat biopsies produce a diagnostic result. For the small minority of nodules that remain non-diagnostic, the next steps depend on the ultrasound features and clinical context.
Schedule a repeat biopsy at 6 to 8 weeks with an operator experienced in thyroid biopsy.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Needle Biopsy (FNA) series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →